Incyte Reports 2018 Fourth Quarter and Year-End Financial Results, Provides 2019 Financial Guidance and Provides Updates on Key Clinical Programs
Go back to Incyte Reports 2018 Fourth Quarter and Year-End Financial Results, Provides 2019 Financial Guidance and Provides Updates on Key Clinical Programs| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 103.66 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $103.66 | 52 Week High | $118.49 | |||
| Open | $103.66 | 52 Week Low | $55.00 | |||
| Day High | $103.66 | P/E | N/A | |||
| Day Low | $103.66 | EPS | $-0.56 | |||
| Volume | 613 | |||||
